Piramal Pharma shares rose 8.3% after JM Financial initiated coverage with a target price of Rs 340, citing strong growth potential driven by its CDMO business and differentiated offerings. The target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback